Pulmonary Embolism

FDA approves XARELTO Starter Pack for DVT

FDA has approved the XARELTO Starter Pack™ for deep vein thrombosis or pulmonary embolism. The medication is use to reduce the risk of stroke or blood clots in those with atrial fibrillation not caused by a heart valve problem.

Xarelto may be alternative for cancer patients with VTE

Patients with cancer who have had venous thromboembolism may have lower risk of bleeding with XARELTO® (rivaroxaban) , a study in Lancet Haematology suggests

FDA approves new anti-clotting drug for use after hip and knee replacements

The Food and Drug Administration has approved a new oral anticoagulant that helps prevent deep vein thrombosis in people recovering from knee or hip replacements.